Guidance Archives - Page 31 of 637

1 minute read

Atmos Energy Raises FY24 EPS Guidance From $6.45-$6.65 To $6.70-$6.80 Vs $6.60 Est.

May 8, 4:56 PM

OutlookFiscal 2024 earnings per diluted share guidance raised to the range of $6.70 - $6.80 from $6.45 - $6.65 per diluted share.Fiscal 2024 capital expenditure guidance increased to approximately $3.1 billion.The

ATO

1 minute read

Enhabit Reaffirms FY24 EPS Guidance Of $0.12-$0.43 Vs $0.25 Est.; Revenue $1.076B-$1.102B Vs $1.08B Est.

By Benzinga Newsdesk

May 8, 4:44 PM

GUIDANCEThe Company reaffirmed its full-year 2024 guidance as follows: ($ in millions, except per share data)2024 Guidance Net service revenue$1,076 to $1,102Adjusted EBITDA$98 to $110Adjusted EPS$0.12 to

EHAB

1 minute read

Jamf Sees Q2 Revenue $150.5M-$152.5M Vs $150.45M Est.; FY24 Revenue $618.5M-$622.5M Vs $617.45M Est.

By Benzinga Newsdesk

May 8, 4:41 PM

For the second quarter of 2024, Jamf currently expects:•Total revenue of $150.5 to $152.5 million•Non-GAAP operating income of $21.5 to $22.5 millionFor the full year 2024, Jamf currently expects:•Total revenue of $618.5

JAMF

1 minute read

Brightcove Sees Q2 2024 Revenue $47.5M-$48.5M Vs $48.48M Estimate, Sees Adj. EPS $(0.05)-$(0.03) Vs $(0.03) Estimate

By Benzinga Newsdesk

May 8, 4:37 PM

Second Quarter 2024 Guidance:Revenue is expected to be in the range of $47.5 million to $48.5 million, including approximately $1.8 million of professional services revenue and $0.8 million of overages.Non-GAAP income

BCOV

1 minute read

Crane NXT Sees FY24 EPS $4.10-$4.35 Vs $4.26 Est.; Raises Sales Growth Guidance To 5%-8% ( Previous -1% To 3%)

By Benzinga Newsdesk

May 8, 4:36 PM

Full Year 2024 GuidanceThe Company is updating its initial full year guidance provided on February 14, 2024, for certain metrics to include the acquisition of OpSec Security. There is no change to the core sales growth

CXT

1 minute read

Sabra Health Care REIT Sees FY24 Normalized AFFO $1.39-$1.43

By Benzinga Newsdesk

May 8, 4:33 PM

2024 GUIDANCESabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):Net Income: $0.53 - $0.57FFO: $1.33 - $1.37Normalized FFO: $1.34 - $1.38AFFO:

SBRA

1 minute read

ACV Auctions Sees Q2 Revenue $154M-$158M Vs $157.93M Est.; FY24 Revenue $610M-$625M Vs $612.9M Est.

By Benzinga Newsdesk

May 8, 4:31 PM

Second Quarter and Full-Year 2024 GuidanceBased on information as of today, ACV is providing the following guidance:Second Quarter of 2024:Total revenue of $154 to $158 million, an increase of 24% to 27% year over

ACVA

1 minute read

Robinhood Markets Sees FY24 Adjusted Operating Expenses And SBC Of $1.85B-$1.95B

By Benzinga Newsdesk

May 8, 4:29 PM

Financial Outlookfor the Year Ending December 31, 2024 Outlook(in millions) Total operating expenses (GAAP)$1,850 - $1,950Significant reconciliation items(1)—Adjusted Operating Expenses and SBC (non-GAAP)$1,850

HOOD

1 minute read

DocGo Sees FY24 Revenue $720M-$750M Vs $747M Estimate

By Benzinga Newsdesk

May 8, 4:17 PM

2024 GuidanceGiven that the previously forecasted wind-down of migrant related services has been accelerated, the Company is revising 2024 revenue guidance from $720-$750 million to $600-$650 million, with an expected

DCGO

2 minute read

Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable

By Vandana Singh

May 8, 3:43 PM

Definitive Healthcare reports Q1 adjusted EPS of $0.08, sales at $63.48M, and adjusted EBITDA of $20 million. Q2 revenue guidance: $62–$63.5 million. FY 2024 revenue outlook: $255–$261 million.